ମଳାଶୟ କର୍କଟ

A dose titration study and a combined superiority registry-based open-label randomized control trial is planned to answer the trial objectives. The study will be registry-based to allow simpler and more comprehensive follow-up. Patients with colorectal cancer will be treated with cytoreductive surgery (CRS) together with either standard oxaliplatin HIPEC (the control for the efficacy study) or oxaliplatin/irinotecan HIPEC in combination with 5-FU 24-hour EPIC. The 5-FU will be administered postoperatively when the abdomen is completely sutured. The drug is divided equally into 2 injections of …

ସ୍ପୋନ୍ସର: ଉପସାଲା ୟୁନିଭରସିଟି
କ୍ଲିନିକାଲ୍ ଟ୍ରାଏଲ୍ସ.gov ରେ NCT04861558
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ୍ 30 ମେ 2025 · ଆମ ଦ୍ୱାରା 20 ଅକ୍ଟୋବର 2026 ରେ ପଢାଯାଇଛି